Retinal vascular permeability suppression by topical application of a novel VEGFR2/Src kinase inhibitor in mice and rabbits. - Wikidata - wikimedia - TriplyDB

Retinal vascular permeability suppression by topical application of a novel VEGFR2/Src kinase inhibitor in mice and rabbits.

Retinal vascular permeability suppression by topical application of a novel VEGFR2/Src kinase inhibitor in mice and rabbits.

http://www.wikidata.org/entity/Q33335166

about

Glycosaminoglycan remodeling during diabetes and the role of dietary factors in their modulation Regulation of Endothelial Adherens Junctions by Tyrosine Phosphorylation Overexpression of nuclear transport factor 2 may protect against diabetic retinopathy A role for a CXCR2/phosphatidylinositol 3-kinase gamma signaling axis in acute and chronic vascular permeability.VEGFR2 induces c-Src signaling and vascular permeability in vivo via the adaptor protein TSAd.The mouse retina as an angiogenesis model.From combinatorial peptide selection to drug prototype (I): targeting the vascular endothelial growth factor receptor pathway.Local acting Sticky-trap inhibits vascular endothelial growth factor dependent pathological angiogenesis in the eye.Src-induced tyrosine phosphorylation of VE-cadherin is not sufficient to decrease barrier function of endothelial monolayers.PEDF regulates vascular permeability by a γ-secretase-mediated pathway.Oligo-guanosine nucleotide induces neuropilin-1 internalization in endothelial cells and inhibits angiogenesis Heparan sulfate regulates VEGF165- and VEGF121-mediated vascular hyperpermeability.Inhibition of thyroid hormone receptor locally in the retina is a therapeutic strategy for retinal degeneration.Modulation of VEGF-induced retinal vascular permeability by peroxisome proliferator-activated receptor-β/δ.Resveratrol attenuates diabetic nephropathy via modulating angiogenesis.An anti-inflammatory role of VEGFR2/Src kinase inhibitor in herpes simplex virus 1-induced immunopathology.Endotoxin-induced monocytic microparticles have contrasting effects on endothelial inflammatory responses.Investigation of retinal morphology alterations using spectral domain optical coherence tomography in a mouse model of retinal branch and central retinal vein occlusion.Interaction of kindlin-2 with integrin β3 promotes outside-in signaling responses by the αVβ3 vitronectin receptor Vitreous inflammatory factors and serous retinal detachment in central retinal vein occlusion: a case control series.Protein kinase cβ phosphorylates occludin regulating tight junction trafficking in vascular endothelial growth factor-induced permeability in vivo.VEGF Receptor-2-Linked PI3K/Calpain/SIRT1 Activation Mediates Retinal Arteriolar Dilations to VEGF and Shear Stress.Semaphorin 6A regulates angiogenesis by modulating VEGF signaling Topical pazopanib blocks VEGF-induced vascular leakage and neovascularization in the mouse retina but is ineffective in the rabbit.High glucose-induced changes in hyaloid-retinal vessels during early ocular development of zebrafish: a short-term animal model of diabetic retinopathy.An in vivo assay to test blood vessel permeability.Zinc and diabetic retinopathy.The regulatory role of hepatoma-derived growth factor as an angiogenic factor in the eye.Quantitative Proteomics Reveals β2 Integrin-mediated Cytoskeletal Rearrangement in Vascular Endothelial Growth Factor (VEGF)-induced Retinal Vascular Hyperpermeability.Lack of R-Ras Leads to Increased Vascular Permeability in Ischemic Retinopathy.Occludin phosphorylation and ubiquitination regulate tight junction trafficking and vascular endothelial growth factor-induced permeability.MicroRNA regulation of endothelial TREX1 reprograms the tumour microenvironment Molecular mechanisms of endothelial hyperpermeability: implications in inflammation.CD44 expression in endothelial colony-forming cells regulates neurovascular trophic effect.Autophagy in Diabetic Retinopathy.Potential Therapeutic Roles for Inhibition of the PI3K/Akt/mTOR Pathway in the Pathophysiology of Diabetic Retinopathy.Early applications of granulocyte colony-stimulating factor (G-CSF) can stabilize the blood-optic-nerve barrier and ameliorate inflammation in a rat model of anterior ischemic optic neuropathy (rAION).Secretogranin III as a disease-associated ligand for antiangiogenic therapy of diabetic retinopathy VEGF165-induced vascular permeability requires NRP1 for ABL-mediated SRC family kinase activation.Estimating outflow facility through pressure dependent pathways of the human eye.

P2860

Q26766645-53CED03D-6F1D-4626-8023-1FC247A9180E Q26778080-90463993-624A-4516-8FDD-B8769C38875C Q28565784-7F1F163D-F604-47E9-9E45-B2E34D429742 Q28566820-1E6915B9-A641-4001-8B07-FBC3EEDFECB5 Q30423029-07652BED-1100-466A-BA5A-E231931648E6 Q30495106-99DDD863-6698-49BA-AECF-F78203A22595 Q33535171-7F46800E-01C4-4DF0-A9A9-C5B69F3A5C20 Q33623357-E5E7FE59-0C56-4C92-9301-CCEAFA5CCA54 Q33747972-0C8050B6-74FB-4874-8CAE-F300B8FC1687 Q33939170-7C5DA486-2774-48C4-BEF4-19E14018EBD1 Q34282386-D479CA94-5CFA-4E15-8B8B-7FC68EA3E82A Q34452740-EBA18332-2C3F-4029-B8AA-35A0C34BA139 Q34555545-034C335B-296F-4567-A574-C2495858D6D0 Q34741796-238C453A-9ABB-4D31-889E-27FD3E450793 Q35061522-C39935B0-D0D4-4C6E-AB81-406F46FBF3D8 Q35076957-D79A720D-697C-45A6-96ED-83058867974D Q35124934-9F98EC87-0587-4251-A7AA-896C634B5BC2 Q35182315-9C9114C5-7E87-441C-9116-44D06FC62EDE Q35197456-0B42F0C5-78AE-44F9-8B22-60CDC0CF361B Q35658364-27451EDB-D504-409B-97DC-57E851428AD7 Q35976653-6D2695BF-E470-47FA-B0D9-B5393458FE75 Q35980480-D602216A-F389-486C-96B3-E9C4FDFBBCBC Q36395624-FC4F4817-77AB-49FD-B6D0-167C1588668E Q36573796-DBAC432E-28B2-4AE9-A29A-97E4ED88A0BD Q36744177-CD810B75-6B6D-4A2F-8EA1-B0ECA0011A8A Q36804454-F07A1C40-7889-4633-8B13-A13CF53176DA Q36825635-523599CA-9387-4DDD-8D3A-C7FB53380F6A Q36828146-7B63050B-2402-41C5-86AB-05EA253ED14C Q36876125-A09D79FF-9E7C-4056-89F4-34534BB09D5C Q37275313-F86625ED-4373-483C-AB52-F8778416D271 Q37344103-AED9E457-8912-4C21-8946-70DEDF51152C Q37464945-67F9C7DC-629F-47DF-B59E-96D336C948AE Q37535022-9698240B-F878-473B-B56E-A377D367C556 Q37599559-AD4F14E7-86E5-4736-B332-4827A9AD2F16 Q37677015-34DAFC80-B66D-4F33-8B71-5788BDABDFD5 Q38895113-24883509-6915-4EEC-9898-290A90BBD492 Q41628540-47BF5458-417B-455A-85CB-35B69F50B66D Q42292862-24A12DCC-FDA9-4772-988C-1851D4BB75B6 Q42292864-D37583E7-D9BC-4E39-A134-D82A110BEC70 Q47231345-C15380A5-18EC-4552-96F0-B03C3C16B21E

P2860

Retinal vascular permeability suppression by topical application of a novel VEGFR2/Src kinase inhibitor in mice and rabbits.

http://www.wikidata.org/entity/Q33335166

description

2008 nî lūn-bûn

@nan

2008 թուականի Յունիսին հրատարակուած գիտական յօդուած

@hyw

2008 թվականի հունիսին հրատարակված գիտական հոդված

@hy

2008年の論文

@ja

2008年学术文章

@wuu

2008年学术文章

@zh-cn

2008年学术文章

@zh-hans

2008年学术文章

@zh-my

2008年学术文章

@zh-sg

2008年學術文章

@yue

name

Retinal vascular permeability ...... inhibitor in mice and rabbits.

@ast

Retinal vascular permeability ...... inhibitor in mice and rabbits.

@en

Retinal vascular permeability ...... inhibitor in mice and rabbits.

@nl

type

label

Retinal vascular permeability ...... inhibitor in mice and rabbits.

@ast

Retinal vascular permeability ...... inhibitor in mice and rabbits.

@en

Retinal vascular permeability ...... inhibitor in mice and rabbits.

@nl

prefLabel

Retinal vascular permeability ...... inhibitor in mice and rabbits.

@ast

Retinal vascular permeability ...... inhibitor in mice and rabbits.

@en

Retinal vascular permeability ...... inhibitor in mice and rabbits.

@nl

P1433

Q33335166-FEA77B12-3218-4FF4-9228-C56C2C75D300

P1476

Q33335166-C9F44922-9EAD-4BD2-A439-1DB0E3D57EEB

P2093

Q33335166-0308E3CA-B841-44BA-B413-3897964CBCFE

Q33335166-2A535676-A214-4F49-9EA5-3B0EEC1E7084

Q33335166-36AFD5E6-8C67-42AB-9F32-8A8298ECE5C3

Q33335166-660B5100-6DA8-4AF3-A765-0DB35160E8D3

Q33335166-78B97078-E092-4EC3-88D2-27404DDA3851

Q33335166-8C3B39FF-758F-4B97-A0DC-5C03C5FD3EF1

Q33335166-A78EDF6B-6474-42E5-9CB5-2E4B2185CAD4

Q33335166-AA25532D-D088-4C33-9A77-1CF5559C2B65

Q33335166-AADE8424-2929-4E13-B88E-A4A237183AF4

Q33335166-B9C7BEFA-54D2-43E0-9A38-E1D3EB283EEA

P2860

Q33335166-0111490B-E197-434B-ADF7-11458114BDA3

Q33335166-05CBA33D-9E6A-4815-AF5A-02B159A05395

Q33335166-1A3BFDE6-B25F-441D-8745-E2935D4AC3EC

Q33335166-1D6B0304-8A78-4A72-8C4F-E617BCE85EF9

Q33335166-29943935-64D1-4BA6-8453-B4415B1722B6

Q33335166-3396FBC7-0D66-4F7A-ACF2-FDD56C73CED5

Q33335166-441A7D61-AB84-4A83-BEFF-AE3145C6FBC9

Q33335166-4B4AEEB3-99BB-47FD-BA2F-1E9178A810EB

Q33335166-508580FC-3F6E-495A-900D-549972D695D5

Q33335166-52A01F1F-8D8D-41C4-98E6-4A6623500228

P304

Q33335166-9FD93E6E-6E86-4E5D-9468-115B22702737

P31

Q33335166-BA712503-44BF-4DDC-8066-E715975BB992

P356

Q33335166-E747EF12-FF42-4D8C-8F35-8D7DE1330112

P407

Q33335166-D9E8B8F3-CE66-4ABE-B6CB-3153D5EF8A34

P433

Q33335166-F33B8067-EAE9-4A72-BEBB-C4D2C1076F64

P478

Q33335166-37D9929D-1F13-408E-90F7-11D0050A098E

P577

Q33335166-0917D054-3FFA-4B3C-8722-8C042A9E5532

P5875

Q33335166-5BE45520-1423-47F5-BE51-B1172E85A59B

P698

Q33335166-6F11DB6D-49D2-4291-94EF-C022B98AA2EF

P932

Q33335166-E6FF6E75-EA72-484A-B2CF-06040CD1C040

P356

P1433

Journal of Clinical Investigation

P1476

Retinal vascular permeability ...... inhibitor in mice and rabbits.

@en

P2093

David A Cheresh

http://www.w3.org/2001/XMLSchema#string

Edith Aguilar

http://www.w3.org/2001/XMLSchema#string

Glenn Noronha

http://www.w3.org/2001/XMLSchema#string

John Doukas

http://www.w3.org/2001/XMLSchema#string

John Hood

http://www.w3.org/2001/XMLSchema#string

Jon Cao

http://www.w3.org/2001/XMLSchema#string

Lea Scheppke

http://www.w3.org/2001/XMLSchema#string

Martin Friedlander

http://www.w3.org/2001/XMLSchema#string

Michael B Martin

http://www.w3.org/2001/XMLSchema#string

Ray F Gariano

http://www.w3.org/2001/XMLSchema#string

P2860

VEGF: once regarded as a specific angiogenic factor, now implicated in neuroprotection

SU6656, a selective src family kinase inhibitor, used to probe growth factor signaling

Src-mediated coupling of focal adhesion kinase to integrin alpha(v)beta5 in vascular endothelial growth factor signaling.

Src kinase becomes preferentially associated with the VEGFR, KDR/Flk-1, following VEGF stimulation of vascular endothelial cells.

The biology of VEGF and its receptors

Ranibizumab for neovascular age-related macular degeneration

Diabetic retinopathy and diabetic macular edema: pathophysiology, screening, and novel therapies.

Correlation of increased vascular endothelial growth factor with neovascularization and permeability in ischemic central vein occlusion.

Differential regulation of alternatively spliced endothelial cell myosin light chain kinase isoforms by p60(Src).

Sensitive blood-retinal barrier breakdown quantitation using Evans blue.

P304

2337-2346

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1172/JCI33361

http://www.w3.org/2001/XMLSchema#string

P407

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

118

http://www.w3.org/2001/XMLSchema#string

P577

2008-06-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

5366261

http://www.w3.org/2001/XMLSchema#string

P698

18483622

http://www.w3.org/2001/XMLSchema#string

P932

2381746

http://www.w3.org/2001/XMLSchema#string